Related Experiment Video

Updated: Jul 10, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice

Burhan I Ghanayem1, Undi Hoffler

  • 1Metabolism and Exposure Markers Section, Laboratory of Pharmacology and Chemistry, National Toxicology Program, NIEHS, NIH, RTP, NC 27709, USA. Ghanayem@niehs.nih.gov

Current Drug Metabolism
|November 6, 2007
PubMed

Insights

Cytochrome P450 2E1 knockout mice (Cyp2e1-/-) are valuable for studying how xenobiotics cause toxicity and cancer. These mice help understand the metabolic pathways leading to adverse health effects from environmental chemicals.

Area of Science:

  • Biochemistry
  • Toxicology
  • Genetics

Background:

  • Cytochromes P450 (CYPs) are crucial enzymes in metabolizing drugs and environmental chemicals.
  • Cytochrome P450 2E1 (CYP2E1) plays a key role in bioactivating many small, hydrophobic compounds into toxic or carcinogenic forms.
  • Genetically engineered knockout mice offer a precise tool to study the specific roles of individual CYPs in xenobiotic metabolism and toxicity.

Purpose of the Study:

  • To review studies utilizing Cyp2e1 knockout mice to elucidate the mechanisms of xenobiotic-induced toxicity, genotoxicity, and carcinogenicity.
  • To evaluate the utility of Cyp2e1-/- mice in understanding the metabolic fate and biological consequences of various xenobiotics.
  • To compare the effectiveness of using Cyp2e1-/- mice versus chemical modulators in studying CYP-mediated xenobiotic effects.

Main Methods:

  • Utilizing Cyp2e1 knockout mice (Cyp2e1-/-) to investigate xenobiotic metabolism and toxicity.
  • Analyzing studies that examine the complete pathway from xenobiotic metabolism to toxicity, genotoxicity, and carcinogenicity.
  • Comparing results from studies where substrates are primarily metabolized by CYP2E1 versus those metabolized by multiple CYP enzymes.

Main Results:

  • Cyp2e1-/- mice provide comprehensive insights into xenobiotic metabolism-to-toxicity pathways, especially for substrates primarily metabolized by CYP2E1 (e.g., urethane, acrylamide).
  • Studies involving substrates metabolized by multiple CYPs (e.g., trichloroethylene) present greater complexity, often necessitating the use of chemical inducers or inhibitors.
  • The use of Cyp2e1-/- mice allows for a detailed characterization of the enzymatic, metabolic, and molecular mechanisms underlying xenobiotic-induced adverse effects.

Conclusions:

  • Cyp2e1-/- mice are an indispensable animal model for investigating the metabolic and molecular underpinnings of xenobiotic toxicity, genotoxicity, and carcinogenicity.
  • This model is particularly powerful for substrates predominantly metabolized by CYP2E1, offering clear insights into specific metabolic activation pathways.
  • For complex substrates involving multiple CYPs, a combination of knockout models and chemical modulators may be required for a complete understanding.

More Related Videos

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans10:55

Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans

Published on: February 22, 2015

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...